| Literature DB >> 21464073 |
Abstract
The healthcare burden is increasing in both the developed and the developing world and there is widespread acceptance that the historical pharmaceutical business model is not sustainable. In order to meet the healthcare challenge, companies and academia need to develop new business models to increase the probability of success and decrease the cost of failure. New partnerships have already emerged in the area of neglected diseases and other models for diseases of the developed world are emerging.Entities:
Mesh:
Year: 2011 PMID: 21464073 DOI: 10.1098/rsta.2010.0377
Source DB: PubMed Journal: Philos Trans A Math Phys Eng Sci ISSN: 1364-503X Impact factor: 4.226